United States· US:50488-0901_1b45f6d1-4436-4b3a-813b-7043c0d0fad6
Laxacin
A medicinal product containing docusate sodium; sennosides a and b, registered in United States by Alexso, Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DOCUSATE SODIUM; SENNOSIDES A AND B
- Manufacturer
- Alexso, Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc115048809011100 TABLET in 1 BOTTLE (50488-0901-1)
- ndc1150488-0901-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6adc7820-11f9-4f0c-9a2b-8b646c235a92 GET /v1/drugs/6adc7820-11f9-4f0c-9a2b-8b646c235a92?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50; 8.6",
"substance": "DOCUSATE SODIUM; SENNOSIDES A AND B",
"productndc": "50488-0901",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "M007",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about docusate sodium; sennosides a and b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.